News

Schlieren/Osaka - Memo Therapeutics and Ono Pharmaceutical, one of Japan’s largest pharma companies, have entered into a research and development (R&D) collaboration to discover antibodies for immuno-oncology targets. Their aim is to generate new drug candidates for cancer patients.

Zug/New York - Lukka has established its European headquarters in the Greater Zurich Area. The data and software company for cryptocurrency investments is seeking to expand its European operations from its new base. In terms of motivation for its choice of location, Lukka cites the innovative power and risk appetite on the part of local companies.

Collina d'Oro - IBSA Institut Biochimique has opened COSMOS, the multinational Group’s largest production facility, at its headquarters in the Greater Zurich Area. Keynote speeches praised the company as a critical resource for innovation and transfer processes as well as the social fabric of the region.

Lugano - USI, SUPSI, Franklin University Switzerland and the city of Lugano have signed a framework agreement for the implementation of the Lugano Plan B project. This aims to promote the adoption of blockchain and Bitcoin throughout the city in addition to transforming Lugano into a hub for these technologies.

Schlieren/San Antonio - The start-up Hemotune has been awarded the Europe Technology Innovation Leadership Award 2022 by Frost & Sullivan. The company received this recognition for its blood purification technology known as HemoSystem.

Lugano/Kloten/Zurich - Nexoya has been named as the winner of the Food Tech Award 2022 in the category of Data-Based Added Value. Adventr from the USA won in the second category. Both start-ups will now have the opportunity to discuss a pilot project with the award organizers Barilla and Lavazza.

Zurich - Timly Software AG is substituting its barcode scanner for a solution developed by Scandit. This will make Timly’s digital inventory management solution three times faster by collecting data using smartphones, drones, digital glasses and robots.

Zurich - Researchers at the Swiss Federal Institute of Technology Zurich have proven that bacteria used as vehicles for cancer drugs can efficiently penetrate the blood vessel wall and into tumor tissue. This is made possible by magnetic fields.

Zurich - Several financial backers have invested a total of 12 million US dollars in LatticeFlow’s computer vision platform based on artificial intelligence (AI). It supports engineers who use models by detecting and correcting blind spots in their data and models.